CervoMed Inc. (CRVO) Insider Trading Activity

NASDAQ$8.47
Market Cap
$73.71M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
328 of 875
Rank in Industry
186 of 504

CRVO Insider Trading Activity

CRVO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$53,971
2
100
Sells
$0
0
0

Related Transactions

ELDER WILLIAM ROBERTCFO & GC
2
$53,971
0
$0
$53,971

About CervoMed Inc.

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.

Insider Activity of CervoMed Inc.

Over the last 12 months, insiders at CervoMed Inc. have bought $53,971 and sold $0 worth of CervoMed Inc. stock.

On average, over the past 5 years, insiders at CervoMed Inc. have bought $53,971 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: ELDER WILLIAM ROBERT (CFO & GC) — $53,971.

The last purchase of 4,233 shares for transaction amount of $35,811 was made by ELDER WILLIAM ROBERT (CFO, GC & Secretary) on 2025‑05‑14.

List of Insider Buy and Sell Transactions, CervoMed Inc.

2025-05-14PurchaseELDER WILLIAM ROBERTCFO, GC & Secretary
4,233
0.0495%
$8.46
$35,811
+3.65%
2024-08-27PurchaseELDER WILLIAM ROBERTCFO & GC
1,000
0.0132%
$18.16
$18,160
-45.29%
Total: 2
*Gray background shows transactions not older than one year

CRVO Institutional Investors: Active Positions

Increased Positions25+47.17%1M+78.97%
Decreased Positions23-43.4%319,145-21.85%
New Positions10New975,249New
Sold Out Positions11Sold Out195,945Sold Out
Total Postitions55+3.77%2M+57.12%

CRVO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$3,931.004.26%383,487-16,812-4.2%2024-12-31
Blackrock, Inc.$3,573.003.87%348,623+24,315+7.5%2025-03-31
State Street Corp$1,192.001.29%116,256+11,800+11.3%2024-12-31
Geode Capital Management, Llc$1,177.001.28%114,835-99-0.09%2024-12-31
Woodline Partners Lp$767.000.83%74,852+74,852New2024-12-31
Northern Trust Corp$522.000.57%50,908-2,784-5.18%2024-12-31
Morgan Stanley$519.000.56%50,628+5,525+12.25%2024-12-31
Ubs Group Ag$444.000.48%43,365+40,828+1,609.3%2024-12-31
Nuveen Asset Management, Llc$426.000.46%41,569+22,104+113.56%2024-12-31
Qube Research & Technologies Ltd$287.000.31%28,021+28,021New2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.